{"count":6,"index":{"built_at":"2026-07-26T19:53:59.197892+00:00","public_records":55311,"revision":"260d00235774cda99d67da54"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: CYP2D6 in the context of menopause"},"results":[{"answer":"The question about CYP2D6 in the context of menopause is relevant because this enzyme metabolizes several drugs commonly used during this life stage, including selective serotonin reuptake inhibitors (SSRIs) for hot flashes and tamoxifen for breast cancer prevention or treatment. CYP2D6 variants can slow or accelerate drug metabolism, potentially affecting efficacy and side effects. However, the evidence for routine genetic testing in menopause is limited. Most studies are observational or pharmacokinetic; large randomized controlled trials demonstrating clinical utility are lacking. Moreover, CYP2D6 influence is confounded by liver function, co-medications, and diet. The American Society of Clinical Oncology does not recommend routine CYP2D6 testing for tamoxifen due to inconsistent data. For SSRIs, no clear guideline exists. There is no direct evidence that a specific CYP2D6 variant itself influences menopausal symptoms. Therefore, caution is warranted: a genetic test may provide hints but should not be the sole basis for decisions. The evidence is rated as unclear because the provided context contains no specific data on CYP2D6 and menopause. Always consult a physician before adjusting medications based on genetic results.","area":"gesundheit","canonical_id":"gesundheit:canonical-e24c8cfdded239c9a7cc2074","id":"public-db1ecd9a2be84d5af3d466df","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: CYP2D6 in the context of menopause","score":23.18199845,"snippet":"The question about CYP2D6 in the context of menopause is relevant because this enzyme metabolizes several drugs commonly used during this life stage, including selective serotonin reuptake inhibitors (SSRIs) for hot flashes and tamoxifen for breast cancer prevention or treatment. CYP2D6 variants can slow or accelerate drug metabolism, potentially affecting efficacy and side effects. However, the evidence for routine genetic testing in menopause is limited. Most studies are observational or pharmacokinetic; large randomized controlled trials demonstrating clinical utility are lacking. Moreover, CYP2D6 influence is confounded by liver function, co-medications, and diet. The American Society of","sources":[],"title":"Evidence check: CYP2D6 in the context of menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-db1ecd9a2be84d5af3d466df/evidence-check-cyp2d6-in-the-context-of-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"CYP2D6 is a key drug-metabolizing enzyme responsible for processing about 25% of all medications, including many antidepressants (e.g., SSRIs like paroxetine) and tamoxifen. During menopause, such drugs are often prescribed – for hot flashes or breast cancer therapy. Genetic variants in CYP2D6 can alter metabolic rate: 'poor metabolizers' face higher drug levels and increased side effect risk, while 'ultrarapid metabolizers' may experience underdosing. However, evidence for a direct effect of CYP2D6 on the natural course of menopause or on non-drug symptoms is weak. Most studies focus on pharmacokinetics, not on menopause as a physiological condition. Therefore, CYP2D6 testing in the context of menopause is only clinically useful if drug therapy is planned or ongoing. Without medication, the genotype has no relevance for menopausal symptoms. Caution: Do not adjust any medication without medical supervision and without considering liver function and drug interactions.","area":"gesundheit","canonical_id":"gesundheit:canonical-e0ce1c821f37a320841807c6","id":"public-0eb1c74d0bd0d73c4f680f92","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: CYP2D6 in the context of Wechseljahre","score":22.95476475,"snippet":"CYP2D6 is a key drug-metabolizing enzyme responsible for processing about 25% of all medications, including many antidepressants (e.g., SSRIs like paroxetine) and tamoxifen. During menopause, such drugs are often prescribed – for hot flashes or breast cancer therapy. Genetic variants in CYP2D6 can alter metabolic rate: 'poor metabolizers' face higher drug levels and increased side effect risk, while 'ultrarapid metabolizers' may experience underdosing. However, evidence for a direct effect of CYP2D6 on the natural course of menopause or on non-drug symptoms is weak. Most studies focus on pharmacokinetics, not on menopause as a physiological condition. Therefore, CYP2D6 testing in the context","sources":[],"title":"Evidence check: CYP2D6 in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-0eb1c74d0bd0d73c4f680f92/evidence-check-cyp2d6-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The provided context lacks direct evidence on pharmacogenetics (e.g., Medicheck) in menopause. In general, pharmacogenetic tests analyze genetic variants affecting drug metabolism (e.g., CYP2D6, CYP2C19). In menopause, such tests could theoretically guide hormone therapy or other medication choices. However, the evidence base is limited: most studies are small, population-specific, and not prospectively validated. Many consumer tests overstate clinical utility. Moreover, no specific guidelines exist for menopause. Responsible use requires physician oversight and integration with lifestyle, symptoms, and medical history. Therefore, pharmacogenetic testing in menopause remains an adjunctive tool with weak evidence, not a standalone decision-maker.","area":"gesundheit","canonical_id":"gesundheit:canonical-b53af3e4e01941de69be8693","id":"public-0f9a399d12d69ad46d053d2d","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Pharmakogenetik Medicheck in the context of menopause","score":21.61078801,"snippet":"The provided context lacks direct evidence on pharmacogenetics (e.g., Medicheck) in menopause. In general, pharmacogenetic tests analyze genetic variants affecting drug metabolism (e.g., CYP2D6, CYP2C19). In menopause, such tests could theoretically guide hormone therapy or other medication choices. However, the evidence base is limited: most studies are small, population-specific, and not prospectively validated. Many consumer tests overstate clinical utility. Moreover, no specific guidelines exist for menopause. Responsible use requires physician oversight and integration with lifestyle, symptoms, and medical history. Therefore, pharmacogenetic testing in menopause remains an adjunctive to","sources":[],"title":"Evidence check: Pharmakogenetik Medicheck in the context of menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-0f9a399d12d69ad46d053d2d/evidence-check-pharmakogenetik-medicheck-in-the-context-of-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The combination of a Cardio Risk Check and menopause is not directly addressed in the provided context. The available information covers pharmacogenetics (CYP2D6, CYP2C19, VKORC1), hormone tests (without specifying cardiovascular markers), and microbiome/longevity tests. It is well established that menopause increases cardiovascular risk due to estrogen decline, but a consumer DNA or biomarker test alone cannot comprehensively assess this risk. Evidence for such tests in this specific context is unclear – there are no clinically validated studies demonstrating direct benefit. A proper Cardio Risk Check should incorporate traditional risk factors (blood pressure, lipids, glucose, smoking, family history) alongside menopausal status. Without integration into a clinical framework, the test's value remains limited. Safety note: Do not rely solely on a consumer genetic test for cardiovascular risk assessment during menopause; consult a healthcare provider.","area":"gesundheit","canonical_id":"gesundheit:canonical-ccbfaab7adb4f3d36ade19ed","id":"public-c55149e2ad24f5be7e24dcab","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Cardio Risk Check in the context of menopause","score":21.41740962,"snippet":"The combination of a Cardio Risk Check and menopause is not directly addressed in the provided context. The available information covers pharmacogenetics (CYP2D6, CYP2C19, VKORC1), hormone tests (without specifying cardiovascular markers), and microbiome/longevity tests. It is well established that menopause increases cardiovascular risk due to estrogen decline, but a consumer DNA or biomarker test alone cannot comprehensively assess this risk. Evidence for such tests in this specific context is unclear – there are no clinically validated studies demonstrating direct benefit. A proper Cardio Risk Check should incorporate traditional risk factors (blood pressure, lipids, glucose, smoking, fam","sources":[],"title":"Evidence check: Cardio Risk Check in the context of menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-c55149e2ad24f5be7e24dcab/evidence-check-cardio-risk-check-in-the-context-of-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Whether a 'Cardio Risk Check' is useful during menopause depends on what exactly is measured. Menopause increases cardiovascular risk due to declining estrogen, affecting LDL cholesterol, blood pressure, and inflammatory markers. A test covering these classic risk factors may provide some insight, but it cannot replace clinical risk stratification (e.g., SCORE2). The provided context lacks specific studies or product details on a Cardio Risk Check for menopause. Moreover, the context repeatedly warns that consumer DNA tests often miss clinically relevant genes (e.g., CYP2D6, VKORC1) and are not validated for medication dosing. Without menopause-specific validation, the utility of such a check remains unclear. An evidence-based risk assessment should always involve a physician who considers hormonal status, lifestyle, and family history. Therefore, be cautious of overblown claims – the test may offer a rough indication but is no substitute for a clinical evaluation.","area":"gesundheit","canonical_id":"gesundheit:canonical-a7a2a7ad2bca96e9761e0e46","id":"public-a58b147afb05c4a8021b422b","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Is Cardio Risk Check useful for menopause?","score":20.68956079,"snippet":"Whether a 'Cardio Risk Check' is useful during menopause depends on what exactly is measured. Menopause increases cardiovascular risk due to declining estrogen, affecting LDL cholesterol, blood pressure, and inflammatory markers. A test covering these classic risk factors may provide some insight, but it cannot replace clinical risk stratification (e.g., SCORE2). The provided context lacks specific studies or product details on a Cardio Risk Check for menopause. Moreover, the context repeatedly warns that consumer DNA tests often miss clinically relevant genes (e.g., CYP2D6, VKORC1) and are not validated for medication dosing. Without menopause-specific validation, the utility of such a chec","sources":[],"title":"Is Cardio Risk Check useful for menopause?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-a58b147afb05c4a8021b422b/is-cardio-risk-check-useful-for-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Evidence for pharmacogenetic testing (e.g., Medicheck) in menopause is currently **moderate to mixed**. Genetic variants in enzymes like CYP2D6, CYP2C19, or COMT may influence the metabolism of hormone replacement therapy (HRT) or antidepressants. However, large prospective trials demonstrating clinical utility are lacking. Most evidence comes from pharmacokinetic data and observational studies, not RCTs. Routine use is not standard of care. Testing may be considered in individual cases (e.g., unexpected side effects or poor response) but should not replace clinical judgment. Be cautious of marketing claims.","area":"gesundheit","canonical_id":"gesundheit:canonical-e5ad3efe3cc95e0e80df30e3","id":"public-8b7f929c4f5235ca6925b40c","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Pharmakogenetik Medicheck in the context of Wechseljahre","score":20.65161668,"snippet":"Evidence for pharmacogenetic testing (e.g., Medicheck) in menopause is currently **moderate to mixed**. Genetic variants in enzymes like CYP2D6, CYP2C19, or COMT may influence the metabolism of hormone replacement therapy (HRT) or antidepressants. However, large prospective trials demonstrating clinical utility are lacking. Most evidence comes from pharmacokinetic data and observational studies, not RCTs. Routine use is not standard of care. Testing may be considered in individual cases (e.g., unexpected side effects or poor response) but should not replace clinical judgment. Be cautious of marketing claims.","sources":[],"title":"Evidence check: Pharmakogenetik Medicheck in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-8b7f929c4f5235ca6925b40c/evidence-check-pharmakogenetik-medicheck-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}